FDA Review Of Dietary Ingredients For Pharmacy Compounding Could Open Door To Change DSHEA
This article was originally published in The Rose Sheet
Executive Summary
FDA could look for Congress to amend DSHEA as it creates a “deep” administrative record on dietary ingredients placed on a list of substances no longer allowed for use by compounding pharmacies, says integrative medicine attorney Alan Dumoff. Pharmacy organizations are writing a citizen petition to ward off what they fear will be an excuse to step-up regulation of supplement manufacturing and marketing.